You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 11 Sep 2025
Cancer Type:
Lung, 
Mesothelioma (Pleural)
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Rationale/Uses, Drug Regimen and Cycle Frequency sections; Added NDFP form

Sep 2025
Regimen
Published Date: 11 Sep 2025
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Regimen and Cycle Frequency sections

Sep 2025
Regimen
Published Date: 11 Sep 2025
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose Regimen and Cycle Frequency sections

Sep 2025
Drug

Published Date: 11 Sep 2025

Revision Summary:


Drug Monograph: Added NDFP forms; Updated Indications, Adverse effects, Dosage with hepatic impairment, Dosing-Children, Administration Guidelines, and Monitoring sections

Sep 2025
Drug

Published Date: 11 Sep 2025

Revision Summary:
Patient Info Sheet EN: Updated/revised information sheet
Sep 2025
Regimen
Published Date: 10 Sep 2025
Cancer Type:
Gynecologic, 
Endometrial
Intent: Adjuvant, Curative, Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

Sep 2025
Regimen
Published Date: 10 Sep 2025
Cancer Type:
Gynecologic, 
Endometrial
Intent: Adjuvant, Curative, Palliative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Drug Regimen, Cycle Frequency, Dose Modifications, Adverse effects, Administration Guidelines, and Monitoring sections; added NDFP form

Sep 2025
Regimen
Published Date: 10 Sep 2025
Cancer Type:
Gynecologic, 
Endometrial
Intent: Adjuvant, Curative, Palliative
Revision Summary:

Regimen Monograph: Modified rationale/uses and Dose regimen sections; added NDFP form

Sep 2025
Regimen
Published Date: 10 Sep 2025
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Rationale/uses, Supplementary Public Funding and Cycle Frequency sections

Sep 2025
Regimen
Published Date: 10 Sep 2025
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Rationale/uses and Cycle Frequency sections

Sep 2025
Regimen
Published Date: 10 Sep 2025
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Supplementary Public Funding section

Sep 2025
Regimen
Published Date: 09 Sep 2025
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Drug Funding and Drug Regimen sections

Sep 2025

Pages